Carlton Weatherby - 20 Feb 2026 Form 4 Insider Report for Inspire Medical Systems, Inc. (INSP)

Role
Chief Strategy and Growth Officer.
Signature
/s/ Bryan Phillips, Attorney-in-Fact for Carlton Weatherby
Issuer symbol
INSP
Transactions as of
20 Feb 2026
Net transactions value
-$40,004
Form type
4
Filing time
24 Feb 2026, 18:58:04 UTC
Previous filing
18 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Weatherby Carlton Chief Strategy and Growth Officer. C/O INSPIRE MEDICAL SYSTEMS, INC., 5500 WAYZATA BLVD., SUITE 1600, GOLDEN VALLEY /s/ Bryan Phillips, Attorney-in-Fact for Carlton Weatherby 24 Feb 2026 0001986335

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSP Common Stock Award $0 +2,196 +33% $0.000000 8,756 20 Feb 2026 Direct F1
transaction INSP Common Stock Tax liability $40,004 -672 -7.7% $59.53 8,084 20 Feb 2026 Direct F2
transaction INSP Common Stock Award $0 +20,997 +260% $0.000000 29,081 20 Feb 2026 Direct F3
transaction INSP Common Stock Award $0 +12,598 +43% $0.000000 41,679 20 Feb 2026 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects an award of shares of common stock following the satisfaction of performance conditions associated with previously granted performance stock units.
F2 Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award.
F3 Represents an award of restricted stock units ("RSUs"), which vests in three equal annual installments commencing on February 20, 2027. Each RSU represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant dates.

Remarks:

Chief Strategy and Growth Officer.